Longitudinal evaluation of breast tissue in healthy infants: Prevalence and relation to reproductive hormones and growth factors

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Longitudinal evaluation of breast tissue in healthy infants : Prevalence and relation to reproductive hormones and growth factors. / Ljubicic, Marie Lindhardt; Madsen, Andre; Upners, Emmie N.; Fischer, Margit Bistrup; Busch, Alexander Siegfried; Frederiksen, Hanne; Johannsen, Trine Holm; Juul, Anders; Hagen, Casper P.

I: Frontiers in Endocrinology, Bind 13, 1048660, 2022.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Ljubicic, ML, Madsen, A, Upners, EN, Fischer, MB, Busch, AS, Frederiksen, H, Johannsen, TH, Juul, A & Hagen, CP 2022, 'Longitudinal evaluation of breast tissue in healthy infants: Prevalence and relation to reproductive hormones and growth factors', Frontiers in Endocrinology, bind 13, 1048660. https://doi.org/10.3389/fendo.2022.1048660

APA

Ljubicic, M. L., Madsen, A., Upners, E. N., Fischer, M. B., Busch, A. S., Frederiksen, H., Johannsen, T. H., Juul, A., & Hagen, C. P. (2022). Longitudinal evaluation of breast tissue in healthy infants: Prevalence and relation to reproductive hormones and growth factors. Frontiers in Endocrinology, 13, [1048660]. https://doi.org/10.3389/fendo.2022.1048660

Vancouver

Ljubicic ML, Madsen A, Upners EN, Fischer MB, Busch AS, Frederiksen H o.a. Longitudinal evaluation of breast tissue in healthy infants: Prevalence and relation to reproductive hormones and growth factors. Frontiers in Endocrinology. 2022;13. 1048660. https://doi.org/10.3389/fendo.2022.1048660

Author

Ljubicic, Marie Lindhardt ; Madsen, Andre ; Upners, Emmie N. ; Fischer, Margit Bistrup ; Busch, Alexander Siegfried ; Frederiksen, Hanne ; Johannsen, Trine Holm ; Juul, Anders ; Hagen, Casper P. / Longitudinal evaluation of breast tissue in healthy infants : Prevalence and relation to reproductive hormones and growth factors. I: Frontiers in Endocrinology. 2022 ; Bind 13.

Bibtex

@article{61035c009f624d76a785c4f9f0ffe2df,
title = "Longitudinal evaluation of breast tissue in healthy infants: Prevalence and relation to reproductive hormones and growth factors",
abstract = "Introduction: Breast tissue in infancy is a rather undescribed phenomenon. We aimed to describe the prevalence and progression of palpable breast tissue in healthy boys and girls aged 0-1 years and to evaluate clinical markers, individual serum hormone concentrations as well as combined hormone profiles as determinants of the persistence of breast tissue. Methods: In total, 233 term infants (119 boys, 114 girls) were included and followed from birth until 1 year of age in The COPENHAGEN Minipuberty Study (ClinicalTrials.gov #NTC02784184). Infants were followed up to six times with a clinical examination and serum sampling. Principal component analyses (PCAs) produced combined hormone profiles. Results: A total of 98% of all infants aged 0-1 year exhibited breast tissue at some point. 50% still had breast tissue present at 0.5-0.6 years in girls and 0.3-0.4 years in boys ({\textquoteleft}persistent{\textquoteright}). At one year, more girls than boys had breast tissue present (p=0.010). Most clinical and hormonal markers did not differ in infants with/without persistent breast tissue. However, in those with persistent breast tissue, estradiol (first visit, girls, p=0.034), androstenedione, corticosterone, cortisol (first visit, boys, all p<0.050), length (first visit, boys, p=0.030), and testicular volume (0.3-0.4 years, p=0.040) were higher, while IGF-I (0.3-0.4, boys, p=0.033) was lower. In boys, a combined, PCA-derived hormone profile (first visit) was able to predict the persistence of breast tissue (area under the curve=83%) better than any single marker. Discussion: Palpable breast tissue in infancy is common in both sexes although it persists in significantly more girls than boys at one year of age. Data supports both the early origin of breast tissue (in utero- and early postnatal) as well as a role of endogenous hormone production in later development and maintenance.",
keywords = "breast development, breast tissue, infancy, minipuberty, PCA, principal component analysis, reproductive hormone, thelarche",
author = "Ljubicic, {Marie Lindhardt} and Andre Madsen and Upners, {Emmie N.} and Fischer, {Margit Bistrup} and Busch, {Alexander Siegfried} and Hanne Frederiksen and Johannsen, {Trine Holm} and Anders Juul and Hagen, {Casper P.}",
note = "Publisher Copyright: Copyright {\textcopyright} 2022 Ljubicic, Madsen, Upners, Fischer, Busch, Frederiksen, Johannsen, Juul and Hagen.",
year = "2022",
doi = "10.3389/fendo.2022.1048660",
language = "English",
volume = "13",
journal = "Frontiers in Endocrinology",
issn = "1664-2392",
publisher = "Frontiers Media S.A.",

}

RIS

TY - JOUR

T1 - Longitudinal evaluation of breast tissue in healthy infants

T2 - Prevalence and relation to reproductive hormones and growth factors

AU - Ljubicic, Marie Lindhardt

AU - Madsen, Andre

AU - Upners, Emmie N.

AU - Fischer, Margit Bistrup

AU - Busch, Alexander Siegfried

AU - Frederiksen, Hanne

AU - Johannsen, Trine Holm

AU - Juul, Anders

AU - Hagen, Casper P.

N1 - Publisher Copyright: Copyright © 2022 Ljubicic, Madsen, Upners, Fischer, Busch, Frederiksen, Johannsen, Juul and Hagen.

PY - 2022

Y1 - 2022

N2 - Introduction: Breast tissue in infancy is a rather undescribed phenomenon. We aimed to describe the prevalence and progression of palpable breast tissue in healthy boys and girls aged 0-1 years and to evaluate clinical markers, individual serum hormone concentrations as well as combined hormone profiles as determinants of the persistence of breast tissue. Methods: In total, 233 term infants (119 boys, 114 girls) were included and followed from birth until 1 year of age in The COPENHAGEN Minipuberty Study (ClinicalTrials.gov #NTC02784184). Infants were followed up to six times with a clinical examination and serum sampling. Principal component analyses (PCAs) produced combined hormone profiles. Results: A total of 98% of all infants aged 0-1 year exhibited breast tissue at some point. 50% still had breast tissue present at 0.5-0.6 years in girls and 0.3-0.4 years in boys (‘persistent’). At one year, more girls than boys had breast tissue present (p=0.010). Most clinical and hormonal markers did not differ in infants with/without persistent breast tissue. However, in those with persistent breast tissue, estradiol (first visit, girls, p=0.034), androstenedione, corticosterone, cortisol (first visit, boys, all p<0.050), length (first visit, boys, p=0.030), and testicular volume (0.3-0.4 years, p=0.040) were higher, while IGF-I (0.3-0.4, boys, p=0.033) was lower. In boys, a combined, PCA-derived hormone profile (first visit) was able to predict the persistence of breast tissue (area under the curve=83%) better than any single marker. Discussion: Palpable breast tissue in infancy is common in both sexes although it persists in significantly more girls than boys at one year of age. Data supports both the early origin of breast tissue (in utero- and early postnatal) as well as a role of endogenous hormone production in later development and maintenance.

AB - Introduction: Breast tissue in infancy is a rather undescribed phenomenon. We aimed to describe the prevalence and progression of palpable breast tissue in healthy boys and girls aged 0-1 years and to evaluate clinical markers, individual serum hormone concentrations as well as combined hormone profiles as determinants of the persistence of breast tissue. Methods: In total, 233 term infants (119 boys, 114 girls) were included and followed from birth until 1 year of age in The COPENHAGEN Minipuberty Study (ClinicalTrials.gov #NTC02784184). Infants were followed up to six times with a clinical examination and serum sampling. Principal component analyses (PCAs) produced combined hormone profiles. Results: A total of 98% of all infants aged 0-1 year exhibited breast tissue at some point. 50% still had breast tissue present at 0.5-0.6 years in girls and 0.3-0.4 years in boys (‘persistent’). At one year, more girls than boys had breast tissue present (p=0.010). Most clinical and hormonal markers did not differ in infants with/without persistent breast tissue. However, in those with persistent breast tissue, estradiol (first visit, girls, p=0.034), androstenedione, corticosterone, cortisol (first visit, boys, all p<0.050), length (first visit, boys, p=0.030), and testicular volume (0.3-0.4 years, p=0.040) were higher, while IGF-I (0.3-0.4, boys, p=0.033) was lower. In boys, a combined, PCA-derived hormone profile (first visit) was able to predict the persistence of breast tissue (area under the curve=83%) better than any single marker. Discussion: Palpable breast tissue in infancy is common in both sexes although it persists in significantly more girls than boys at one year of age. Data supports both the early origin of breast tissue (in utero- and early postnatal) as well as a role of endogenous hormone production in later development and maintenance.

KW - breast development

KW - breast tissue

KW - infancy

KW - minipuberty

KW - PCA

KW - principal component analysis

KW - reproductive hormone

KW - thelarche

U2 - 10.3389/fendo.2022.1048660

DO - 10.3389/fendo.2022.1048660

M3 - Journal article

C2 - 36531497

AN - SCOPUS:85144046097

VL - 13

JO - Frontiers in Endocrinology

JF - Frontiers in Endocrinology

SN - 1664-2392

M1 - 1048660

ER -

ID: 330395490